A collaboration between The Wistar Institute and the University of Buea in Cameroon has uncovered the mechanisms for a medicinal plant with anti-HIV potential in Croton oligandrus Pierre & Hutch, a species of African tree that has been used in traditional healing in Cameroon to treat a variety of diseases and conditions including cancers and diabetes.
PharmassêtX Inc., a late-preclinical stage pharmaceutical development company, today announced that the US Patent and Trademark Office has acknowledged receipt of the Company's patent application entitled "CRYSTALLINE FORM OF EPIGALLOCATECHIN-3-GALLATE." PharmassêtX is developing the novel form of epigallocatechin gallate (EGCG) as a prescription drug for the treatment of inflammatory bowel disease (IBD).
The Wistar Institute’s Hubert J.P. Schoemaker Education and Training Center was the recipient of a $100,000 eXperience grant from NIIMBL to support an immersive weeklong training program at the Institute.
Relief is coming for crime scene investigators and toxicologists who have struggled to accurately and swiftly identify drugs that have been seized by law enforcement and may be relied on as evidence at trial, thanks to a research partnership between West Virginia University and the U.S. Drug Enforcement Administration.
A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a susceptible one, according to a study by researchers from the Johns Hopkins Kimmel Cancer Center and Oregon Health & Science University.
Today, Tufts University announced that Loring Tu, a professor in the Department of Mathematics, has made a substantial gift to name the Science and Engineering Complex (SEC) in honor of his late grandfather, Tsungming Tu, who was a world-renowned doctor and expert on pharmacology, toxicology, and medical education. Going forward, the SEC will be known as the Tsungming Tu Complex (TTC).
The Federal Drug Administration is looking to remove the oral phenylephrine ingredient from over-the-counter medicines. ...
Nearly three dozen Binghamton University, State University of New York researchers have been honored for their work by a Stanford University study that looks at the impact of scientists worldwide. The recently released ranking has identified 33 current faculty who were among the top 2% of all researchers in the world in their fields in 2023.
Scientists have identified a molecule that appears to restore normal breathing in mice following a large dose of fentanyl.
Marina Konopleva, M.D., Ph.D., director of the Leukemia Program and co-director of the Blood Cancer Institute at the National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC), has joined forces with Break Through Cancer, a collaborative medical research foundation that supports teams of scientists as they advance treatments for some of the world’s deadliest cancers. Dr. Konopleva will play a pivotal role in the Eradicating Minimal Residual Disease (MRD) in Acute Myelogenous Leukemia (AML) TeamLab.
Inscripta, Inc., a leading life science technology company helping to create the bioeconomy, has successfully completed scale-up runs and is moving into commercial manufacturing of an anti-aging skincare ingredient.
Scientists from Immanuel Kant Baltic Federal University showed that spraying of selenium stimulates the growth of garden sage – a plant, that is used in medicine for treatment of inflammations and diseases of gastrointestinal tract.
A research team has unveiled the unique chemical, microstructural, rheological, and flavor-related properties of four commercially available microalgal species—Arthrospira, Isochrysis, Nannochloropsis, and Tetraselmis.
With its emphasis on opioid overdose prevention, the first guideline for primary care providers from the American Academy of Pediatrics (AAP) on prescribing opioids for acute pain in children and adolescents extends beyond responsible pain management.
New Jersey Gov. Phil Murphy joined Rutgers and community leaders on Oct. 30 at the Child Health Institute in New Brunswick to celebrate a $47.5 million federal grant for the Rutgers Institute for Translational Medicine and Science that will improve health and well-being for New Jersey residents over the next seven years.
A team from Wake Forest University School of Medicine and Atrium Health has been approved for a $2.5 million funding award by the Patient-Centered Outcomes Research Institute (PCORI) to help improve antibiotic prescribing for children with acute respiratory tract infections in outpatient settings.
Latest research in the FASEB Journal reveals an antibody called bFKB1 improves liver disease and atherosclerosis in a mouse model of metabolic dysfunction-associated steatohepatitis (MASH), which is associated with obesity.
In a significant advance against the growing threat of antibiotic-resistant bacteria, , researchers have identified a novel class of antimicrobial agents known as encrypted peptides, which may expand the immune system’s arsenal of tools to fight infection.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right